Journey Medical (DERM) Operating Margin (2020 - 2025)
Historic Operating Margin for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to 8.67%.
- Journey Medical's Operating Margin rose 111100.0% to 8.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.25%, marking a year-over-year increase of 219300.0%. This contributed to the annual value of 24.36% for FY2024, which is 217500.0% down from last year.
- Per Journey Medical's latest filing, its Operating Margin stood at 8.67% for Q3 2025, which was up 111100.0% from 19.16% recorded in Q2 2025.
- In the past 5 years, Journey Medical's Operating Margin ranged from a high of 49.93% in Q3 2023 and a low of 90.02% during Q2 2021
- In the last 5 years, Journey Medical's Operating Margin had a median value of 25.3% in 2025 and averaged 31.87%.
- As far as peak fluctuations go, Journey Medical's Operating Margin tumbled by -781300bps in 2021, and later skyrocketed by 1088300bps in 2023.
- Over the past 5 years, Journey Medical's Operating Margin (Quarter) stood at 51.7% in 2021, then dropped by -21bps to 62.6% in 2022, then soared by 78bps to 13.79% in 2023, then skyrocketed by 219bps to 16.4% in 2024, then tumbled by -153bps to 8.67% in 2025.
- Its Operating Margin stands at 8.67% for Q3 2025, versus 19.16% for Q2 2025 and 25.3% for Q1 2025.